Artemis Investment Management LLP Sells 44,507 Shares of Humana Inc. (NYSE:HUM)

Artemis Investment Management LLP reduced its stake in Humana Inc. (NYSE:HUM) by 68.9% during the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 20,066 shares of the insurance provider’s stock after selling 44,507 shares during the quarter. Artemis Investment Management LLP’s holdings in Humana were worth $6,956,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds and other institutional investors have also added to or reduced their stakes in the business. First Financial Corp IN lifted its position in Humana by 7.2% in the 4th quarter. First Financial Corp IN now owns 343 shares of the insurance provider’s stock valued at $157,000 after acquiring an additional 23 shares in the last quarter. Aurora Investment Counsel lifted its position in Humana by 1.3% in the 4th quarter. Aurora Investment Counsel now owns 2,273 shares of the insurance provider’s stock valued at $1,155,000 after acquiring an additional 29 shares in the last quarter. Walker Financial Services Inc. lifted its position in Humana by 3.9% in the 4th quarter. Walker Financial Services Inc. now owns 795 shares of the insurance provider’s stock valued at $364,000 after acquiring an additional 30 shares in the last quarter. Signaturefd LLC lifted its position in Humana by 1.2% in the 4th quarter. Signaturefd LLC now owns 2,634 shares of the insurance provider’s stock valued at $1,206,000 after acquiring an additional 30 shares in the last quarter. Finally, Brighton Jones LLC lifted its position in Humana by 6.8% in the 4th quarter. Brighton Jones LLC now owns 470 shares of the insurance provider’s stock valued at $215,000 after acquiring an additional 30 shares in the last quarter. 92.38% of the stock is owned by institutional investors.

Humana Trading Up 2.9 %

Shares of HUM stock opened at $373.61 on Friday. Humana Inc. has a 52-week low of $298.61 and a 52-week high of $530.54. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.67 and a current ratio of 1.67. The firm has a market capitalization of $45.02 billion, a PE ratio of 23.26, a PEG ratio of 2.10 and a beta of 0.53. The stock has a fifty day simple moving average of $343.78 and a two-hundred day simple moving average of $351.97.

Humana (NYSE:HUM) last issued its quarterly earnings results on Wednesday, April 24th. The insurance provider reported $7.23 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $6.12 by $1.11. Humana had a return on equity of 17.76% and a net margin of 1.82%. The business had revenue of $29.61 billion during the quarter, compared to analyst estimates of $28.52 billion. During the same quarter in the prior year, the business posted $9.38 EPS. Humana’s revenue for the quarter was up 10.7% compared to the same quarter last year. On average, analysts predict that Humana Inc. will post 16.27 EPS for the current fiscal year.

Humana Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, July 26th. Shareholders of record on Friday, June 28th will be paid a $0.885 dividend. The ex-dividend date of this dividend is Friday, June 28th. This represents a $3.54 dividend on an annualized basis and a yield of 0.95%. Humana’s payout ratio is presently 22.04%.

Analyst Upgrades and Downgrades

Several equities analysts recently issued reports on the company. Argus cut Humana from a “buy” rating to a “hold” rating in a research report on Wednesday, March 13th. Piper Sandler began coverage on Humana in a report on Wednesday. They set an “overweight” rating and a $392.00 price target on the stock. Raymond James began coverage on Humana in a report on Friday, March 22nd. They set a “market perform” rating on the stock. Royal Bank of Canada lowered their price target on Humana from $415.00 to $353.00 and set an “outperform” rating on the stock in a report on Thursday, April 25th. Finally, Jefferies Financial Group lowered their price target on Humana from $411.00 to $381.00 and set a “buy” rating on the stock in a report on Monday, April 22nd. Fourteen analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company’s stock. According to MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus target price of $409.55.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.